Growth Metrics

Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)

Caribou Biosciences has reported Depreciation and Depletion over the past 3 years, most recently at $400000.0 for Q2 2022.

  • Quarterly Depreciation and Depletion rose 100.0% to $400000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $301000.0 through Jun 2022, down 66.56% year-over-year, with the annual reading at $1000.0 for FY2021, 99.89% down from the prior year.
  • Depreciation and Depletion was $400000.0 for Q2 2022 at Caribou Biosciences, up from $300000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $400000.0 in Q2 2022 and troughed at -$699000.0 in Q4 2021.
  • The 3-year median for Depreciation and Depletion is $200000.0 (2020), against an average of $155666.7.
  • Year-over-year, Depreciation and Depletion crashed 449.5% in 2021 and then skyrocketed 100.0% in 2022.
  • A 3-year view of Depreciation and Depletion shows it stood at $200000.0 in 2020, then crashed by 449.5% to -$699000.0 in 2021, then soared by 157.22% to $400000.0 in 2022.
  • Per Business Quant, the three most recent readings for CRBU's Depreciation and Depletion are $400000.0 (Q2 2022), $300000.0 (Q1 2022), and -$699000.0 (Q4 2021).